NIP
MIRM icon

Nicholas Investment Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

Nicholas Investment Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.2M Buy
172,695
+41,392
+32% +$4.16M 1.14% 20
2026
Q1 		$12.1M Sell
131,303
-82,088
-38% -$7.72M 0.88% 35
2025
Q4 		$16.9M Sell
213,391
-3,677
-2% -$264K 1.23% 11
2025
Q3 		$15.9M Buy
217,068
+32,585
+18% +$2.07M 1.22% 12
2025
Q2 		$9.39M Buy
184,483
+11,440
+7% +$509K 0.84% 29
2025
Q1 		$7.8M Buy
173,043
+24,200
+16% +$1.14M 0.8% 36
2024
Q4 		$6.15M Buy
148,843
+4,364
+3% +$182K 0.54% 65
2024
Q3 		$5.63M Buy
+144,479
New +$5.76M 0.52% 67
2024
Q2 		– Sell
-151,002
Closed -$3.79M – 227
2024
Q1 		$3.79M Sell
151,002
-247,881
-62% -$6.81M 0.39% 98
2023
Q4 		$11.8M Sell
398,883
-800,483
-67% -$24.2M 1.38% 14
2023
Q3 		$37.9M Buy
1,199,366
+284,247
+31% +$7.78M 2.83% 4
2023
Q2 		$23.7M Buy
+915,119
New +$24.3M 1.62% 18

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nicholas Investment Partners's MIRM Position: Q2 2026 in Review

Nicholas Investment Partners increased its Mirum Pharmaceuticals (MIRM) stake by 32% in Q2 2026, buying an estimated $4.16M and bringing the position to 172,695 shares worth $20.2M. The position accounts for 1.14% of the portfolio, ranked #20.

Nicholas Investment Partners first reported a position in MIRM in Q2 2023 and has held it in 12 quarters since. The position peaked at $37.9M in Q3 2023. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Nicholas Investment Partners held 172,695 shares of Mirum Pharmaceuticals worth $20.2M as of Q2 2026.
  • Nicholas Investment Partners bought 41,392 Mirum Pharmaceuticals shares in Q2 2026, an estimated $4.16M.
  • Mirum Pharmaceuticals made up 1.14% of Nicholas Investment Partners's portfolio in Q2 2026, its #20 holding.
  • Nicholas Investment Partners first reported a position in Mirum Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • Nicholas Investment Partners's Mirum Pharmaceuticals position peaked at $37.9M in Q3 2023.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.